Yvonne Schrader
Papers
1
Total Citations
7
H-Index
1
About
Yvonne Schrader has made significant contributions to serological diagnostics, particularly in the context of the COVID-19 pandemic. Her research focuses on developing and validating innovative methods for detecting anti-SARS-CoV-2 antibodies, with an emphasis on minimally invasive sampling techniques. Her most cited work, "Detection of anti‐SARS‐CoV‐2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA)" (2021, 7 citations), demonstrates a practical approach to managing the pandemic by enabling at-home or remote sample collection. This method reduces the need for venipuncture and expands testing accessibility, which is crucial for large-scale surveillance and vulnerable populations. Schrader’s contributions highlight the integration of manual and automated extraction processes with high-sensitivity immunoassays, advancing serological testing efficiency. Her work underscores the importance of adaptable diagnostic tools in public health emergencies, offering a scalable solution for antibody monitoring. With a focus on practical, real-world applications, Schrader’s research continues to influence the field of infectious disease diagnostics and pandemic preparedness.
Research Focus
Key Achievements
Top Papers
- 1